Michael Jewett

Michael Jewett has worked in various roles since 2019. Michael was a Co-Founder at Design Pharmaceuticals Inc., Stemloop, Inc., and Pearl Bio. Michael was also a Scientific Advisory Board member at LanzaTech, Lassogen, Inc., Liberum Biotech, BigHat Biosciences, and Nuclera. In 2023, they will begin a role as Professor of Bioengineering at Stanford University.

Michael Jewett attended Stanford University from 1999 to 2005, where they earned a PhD and MS in Chemical Engineering. Before that, they attended the University of California, Los Angeles from 1995 to 1999, where they earned a B.S in Chemical Engineering.